00:00 / 00:00
05:44
09:17
10:15
13:45
13:57
09:19
11:44
09:20
11:22
07:42
09:02
11:05
07:12
Tay-Sachs disease (TSD) is a rare and fatal genetic disorder that primarily affects the nervous system. It is a lysosomal storage disorder caused by a mutation in a gene on chromosome 15, which codes for a lysosomal enzyme called beta-hexosaminidase A (HEX-A). HEX-A normally breaks down a lipid called GM2 ganglioside found in neurons. Without HEX-A, GM2 ganglioside accumulates inside neurons' lysosomes, resulting in symptoms like seizures, motor delay, low muscle tone, and rapid degeneration of the nervous system.
Diagnosis involves determining the activity of HEX A in serum. Genetic testing for HEX A gene mutations and sequencing of the HEX A gene are used for diagnosis and heterozygous carrier detection. There is currently no cure for Tay-Sachs disease, and treatment options are limited. Supportive care, such as physical therapy, feeding assistance, and seizure control, can help to manage symptoms and improve quality of life.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.